行情

AXGN

AXGN

Axogen Inc.
NASDAQ

实时行情|Nasdaq Last Sale

8.37
+0.69
+8.98%
交易中 11:57 04/06 EDT
开盘
8.01
昨收
7.68
最高
8.62
最低
8.00
成交量
17.63万
成交额
--
52周最高
25.84
52周最低
7.56
市值
3.33亿
市盈率(TTM)
-11.2621
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AXGN价格均价为22.80,最高价位30.00,最低价为19.00。

EPS

AXGN 新闻

更多
  • 摩根大通CEO:将出现类似2008年的重大经济衰退
  • 新浪财经 · 3小时前
  • 美股盘前:疫情扩散放缓 道指期货涨逾700点
  • 新浪财经 · 3小时前
  • 跟着美联储做交易:乱世买金果真是“至理名言”?
  • 新浪财经综合 · 4小时前
  • 迪士尼市值蒸发近三成,机构和媒体是怎么看的?
  • 新浪财经-自媒体综合 · 4小时前

所属板块

先进医疗设备和技术
+5.78%
医疗设备和用品
+4.92%

热门股票

代码
价格
涨跌幅

AXGN 简况

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
展开

微牛提供Axogen Inc.(NASDAQ-AXGN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AXGN股票新闻,以帮助您做出投资决策。